Einat Frydman

Vice President, US Product Supply

Einat Frydman is responsible for Ferring US product supply operations.

Einat is an executive with 25 years of pharmaceutical, medical device, biotechnology and life science operations experience, including early-stage, pre-commercial start-up, and commercial manufacturing. Her management experience includes API & Sterile FP manufacturing, materials, engineering, facilities, EH&S, process development, commercial development, validation, distribution and cost modeling. She also has extensive experience in quality manufacturing and quality operations. Prior to assuming her current role, Einat was General Manager of Bio-Technology General (Israel) Ltd., a Ferring Group company and manufacturer of EUFLEXXA® (1% sodium hyaluronate). Before joining Ferring, she spent 18 years with Teva Pharmaceuticals in a variety of positions of increasing responsibility, such as Head of Regulatory Compliance and Head of Quality Assurance, and finally as Executive Director of the sterile manufacturing plant in Israel producing 40 M sterile units for 40 destinations around the world.

Einat holds a Bachelor of Science in Chemical Engineering from Technion – Israel Institute of Technology.

This site contains material about Ferring Pharmaceuticals Inc. (hereinafter "Ferring") and its various products that may be of interest to Ferring's employees and customers, as well as to members of the health care community and the general public. Please feel free to browse this web site. Your access and use of the information contained herein is subject to the following terms and conditions and all applicable laws. By accessing and browsing this web site, you accept, without limitation or qualification, these terms and conditions and acknowledge that they supersede any other agreement between you and Ferring.

All information on this site is intended for US audiences only.

CERVIDIL, CLENPIQ, ENDOMETRIN, EUFLEXXA, FIRMAGON, MENOPUR, NOCDURNA, NOVAREL, and ZOMACTON are registered trademarks of Ferring B.V. INVOCELL is a registered trademark of INVO BioScience. ORTIKOS is a trademark of Sun Pharma Global FZE.

©2008-2020 Ferring Pharmaceuticals.  US-CORP-2000031